Your Location：
Home >
Browse articles >
Risk Identification and Regulation for China's Anti-Commercial Bribery in Medical Device Procurement and Sales Industry
Chinese Medical Sciences Journal   Vol. 40, Issue 2, Pages: 144-149(2025)
Think Tank Forum | Updated：2025-07-21

    • Risk Identification and Regulation for China's Anti-Commercial Bribery in Medical Device Procurement and Sales Industry

    • “Reporting on the latest research in the medical device procurement and sales sector, the article introduces its research progress in the field of anti-commercial bribery. Expert xx established the preventive regulatory framework, which provides solutions to effectively reduce commercial bribery risks and prevent illegal and non-compliant conduct.”

    • DOI：10.24920/004450    

      CLC：

    • Received：17 December 2024，

      Accepted：11 March 2025，

      Published Online：31 May 2025，

      Published：30 June 2025

    Scan QR Code

  • Fu Jie,Xu Jing-Yi,Wang Yue.Risk Identification and Regulation for China's Anti-Commercial Bribery in Medical Device Procurement and Sales Industry[J].Chinese Medical Sciences Journal,2025,40(02):144-149.doi: 10.24920/004450 DOI：

  •  
  •  

0

Views

41

Downloads

0

Scopus

PlumX

>
Alert me when the article has been cited
Submit
Outline
No Sections

Related Articles

No data

Related Author

Jingyi Xu

Related Institution

No data
0